Abstract
The high prevalence of erectile dysfunction in patients with diabetes is caused mainly by vascular and neurological conditions;nevertheless, hypogonadism may also contribute to erectile dysfunction and to changes in mood, libido, body composition, and bone density. Age, obesity, and the assay used to measure testosterone will affect the diagnosis of hypogonadism. This article focuses on the interaction of these conditions and attempts to explain possible mechanisms for observations reported in the literature.
MeSH terms
-
Age Distribution
-
Aged
-
Cross-Sectional Studies
-
Diabetes Mellitus, Type 2 / complications*
-
Diabetes Mellitus, Type 2 / diagnosis
-
Diabetes Mellitus, Type 2 / drug therapy
-
Erectile Dysfunction / epidemiology
-
Erectile Dysfunction / etiology*
-
Erectile Dysfunction / therapy
-
Follow-Up Studies
-
Humans
-
Hypoglycemic Agents / therapeutic use
-
Hypogonadism / drug therapy
-
Hypogonadism / epidemiology
-
Hypogonadism / etiology*
-
Incidence
-
Male
-
Middle Aged
-
Risk Assessment
-
Testosterone / metabolism*
-
Testosterone / therapeutic use
-
Treatment Outcome
-
Vasodilator Agents / therapeutic use
Substances
-
Hypoglycemic Agents
-
Vasodilator Agents
-
Testosterone